Gurdal N, Fayda M, Alishev N, Bakir B, Tastekin D, Aykan F, Gezer U, Balik E, Saglam EK, Oral EN, Gulluoglu M, Kizir A. “Neoadjuvant volumetric modulated arc therapy in rectal cancer and the correlation of pathological response with diffusion-weighted MRI and apoptotic markers.” 2017 Dec 6:0. doi: 10.5301/tj.5000702. [Epub ahead of print]
Fayda M, Gezer U. GAS5 oligonucleotides as therapeutic agents in breast cancer. Transl Cancer Res 2016. doi: 10.21037/tcr.2016.08.4
Fayda M., M. Isin, M. Tambas, M. Guveli, R. Meral, M. Altun, D. Sahin, G. Ozkan, Y. Sanli, H. Isin, E. Ozgur ve U. Gezer, “Do Circulating Long Non-Coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) Predict the Treatment Response in Patients with Head and Neck Cancer Treated with Chemoradiotherapy?” Tumor Biology, 19 October, (2015)
Gürdal N., M. Fayda, B. Bakir, N. Alishev, U. Gezer, D. Tastekin, R. Çiftçi, U. Akbas, D. Sahin, E. Balik, H. Yanar, M. Keskin, M. Ilhan, R.N. Dagoglu, E.K. Saglam, E.N. Oral, F. Aykan ve A. Kizir, “Neoadjuvant Volumetric Modulated Arc Therapy Simultaneous Integrated Boost (SIB-VMAT) With Concurrent Chemotherapy in Rectal Adenocarcinomas and the Correlation of Pathological Response With Diffusion-Weighted MRI and Apoptotic Markers”, American Society for Radiation Oncology 57th Annual Meeting, USA, vol.93(3), pp.E-128, 18-21 October 2015
Karabulut S., F. Tas, D. Tastekin, M. Karabulut, C.T. Yasasever, R. Çiftçi, M. Güveli, M. Fayda, S. Vatansever, M. Serilmez, R. Disci ve A. Aydıner, “The diagnostic, predictive, and prognostic role of serum epithelial cell adhesion molecule (EpCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in breast cancer”, Tumour Biology. Sep;35(9):8849-60, (2014)
Fayda M, Gezer U. GAS5 oligonucleotides as therapeutic agents in breast cancer. Transl Cancer Res 2016. doi: 10.21037/tcr.2016.08.4
Fayda M., M. Isin, M. Tambas, M. Guveli, R. Meral, M. Altun, D. Sahin, G. Ozkan, Y. Sanli, H. Isin, E. Ozgur ve U. Gezer, “Do Circulating Long Non-Coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) Predict the Treatment Response in Patients with Head and Neck Cancer Treated with Chemoradiotherapy?” Tumor Biology, 19 October, (2015)
Gürdal N., M. Fayda, B. Bakir, N. Alishev, U. Gezer, D. Tastekin, R. Çiftçi, U. Akbas, D. Sahin, E. Balik, H. Yanar, M. Keskin, M. Ilhan, R.N. Dagoglu, E.K. Saglam, E.N. Oral, F. Aykan ve A. Kizir, “Neoadjuvant Volumetric Modulated Arc Therapy Simultaneous Integrated Boost (SIB-VMAT) With Concurrent Chemotherapy in Rectal Adenocarcinomas and the Correlation of Pathological Response With Diffusion-Weighted MRI and Apoptotic Markers”, American Society for Radiation Oncology 57th Annual Meeting, USA, vol.93(3), pp.E-128, 18-21 October 2015
Karabulut S., F. Tas, D. Tastekin, M. Karabulut, C.T. Yasasever, R. Çiftçi, M. Güveli, M. Fayda, S. Vatansever, M. Serilmez, R. Disci ve A. Aydıner, “The diagnostic, predictive, and prognostic role of serum epithelial cell adhesion molecule (EpCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in breast cancer”, Tumour Biology. Sep;35(9):8849-60, (2014)